Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Ra Pharmaceuticals, Inc. (RARX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2020 4 NEW ENTERPRISE ASSOCIATES 13 LP (10% Owner) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 6,135,234 shares @ $0
04/03/2020 4 Mathers Edward T (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 15,000 options to buy @ $22.37, valued at $335.6k
Disposed/sold 15,000 options to buy @ $9.9, valued at $148.5k
Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
04/03/2020 4 Treco Douglas A (President and CEO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 234,707 shares @ $48, valued at $11.3M
Disposed/sold 139,371 options to buy @ $2.87, valued at $400k
Disposed/sold 241,460 options to buy @ $2.87, valued at $693k
Disposed/sold 164,285 options to buy @ $5.6, valued at $920k
Disposed/sold 225,000 options to buy @ $16.64, valued at $3.7M
Disposed/sold 125,000 options to buy @ $7.33, valued at $916.3k
Disposed/sold 311,000 options to buy @ $21, valued at $6.5M
Disposed/sold 20,833 restricted stock units @ $0
04/03/2020 4 Lubner David Charles (Executive VP and CFO) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 15,622 shares @ $48, valued at $749.9k
Disposed/sold 115,572 options to buy @ $2.87, valued at $331.7k
Disposed/sold 92,283 options to buy @ $2.87, valued at $264.9k
Disposed/sold 28,571 options to buy @ $5.6, valued at $160k
Disposed/sold 112,500 options to buy @ $16.64, valued at $1.9M
Disposed/sold 62,500 options to buy @ $7.33, valued at $458.1k
Disposed/sold 133,000 options to buy @ $21, valued at $2.8M
Disposed/sold 10,416 restricted stock units @ $0
04/03/2020 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 2,973 shares @ $48, valued at $142.7k
Disposed/sold 2,857 options to buy @ $0.84, valued at $2.4k
Disposed/sold 14,285 options to buy @ $2.87, valued at $41k
Disposed/sold 30,000 options to buy @ $2.87, valued at $86.1k
Disposed/sold 31,428 options to buy @ $5.6, valued at $176k
Disposed/sold 60,000 options to buy @ $16.64, valued at $998.4k
Disposed/sold 26,250 options to buy @ $7.33, valued at $192.4k
Disposed/sold 107,000 options to buy @ $21, valued at $2.2M
Disposed/sold 4,375 restricted stock units @ $0
04/03/2020 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 12,595 shares @ $48, valued at $604.6k
Disposed/sold 46,434 options to buy @ $2.87, valued at $133.3k
Disposed/sold 26,422 options to buy @ $2.87, valued at $75.8k
Disposed/sold 25,000 options to buy @ $5.6, valued at $140k
Disposed/sold 67,500 options to buy @ $16.64, valued at $1.1M
Disposed/sold 55,000 options to buy @ $7.33, valued at $403.2k
Disposed/sold 107,000 options to buy @ $21, valued at $2.2M
Disposed/sold 9,166 restricted stock units @ $0
04/03/2020 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 14,492 shares @ $48, valued at $695.6k
Disposed/sold 11,110 options to buy @ $5.6, valued at $62.2k
Disposed/sold 73,654 options to buy @ $5.6, valued at $412.5k
Disposed/sold 90,000 options to buy @ $16.64, valued at $1.5M
Disposed/sold 62,500 options to buy @ $7.33, valued at $458.1k
Disposed/sold 133,000 options to buy @ $21, valued at $2.8M
Disposed/sold 10,416 restricted stock units @ $0
04/03/2020 4 Cumbo Alexander (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
Disposed/sold 25,000 options to buy @ $12.99, valued at $324.8k
04/03/2020 4 PEARSON TIMOTHY R (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 22,857 options to buy @ $2.87, valued at $65.6k
Disposed/sold 15,000 options to buy @ $22.37, valued at $335.6k
Disposed/sold 15,000 options to buy @ $9.9, valued at $148.5k
Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
04/03/2020 4 King John C (Chief Commercial Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 10,823 shares @ $48, valued at $519.5k
Disposed/sold 190,000 options to buy @ $6.2, valued at $1.2M
Disposed/sold 107,000 options to buy @ $21, valued at $2.2M
Disposed/sold 30,658 restricted stock units @ $0
04/03/2020 4 Shah Rajeev M. (10% Owner) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 4,858,260 shares @ $48, valued at $233.2M
Disposed/sold 15,000 options to buy @ $22.37, valued at $335.6k
Disposed/sold 15,000 options to buy @ $9.9, valued at $148.5k
Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
04/03/2020 4 Heft Robert (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 22,857 options to buy @ $2.87, valued at $65.6k
Disposed/sold 15,000 options to buy @ $22.37, valued at $335.6k
Disposed/sold 15,000 options to buy @ $9.9, valued at $148.5k
Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
04/03/2020 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 4,858,260 shares @ $48, valued at $233.2M
04/03/2020 4 Brennan Aoife (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Disposed/sold 15,000 options to buy @ $19.88, valued at $298.2k
Disposed/sold 25,000 options to buy @ $16.36, valued at $409k
03/18/2020 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 2,288 shares @ $44.25, valued at $101.2k
03/18/2020 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $45.1648, valued at $478.5k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
02/20/2020 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $46.6116, valued at $493.8k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
01/21/2020 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 2,285 shares @ $47.02, valued at $107.4k
01/16/2020 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $46.9505, valued at $497.4k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
12/18/2019 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 2,285 shares @ $47.0759, valued at $107.6k
12/18/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $47.0821, valued at $470.8k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
12/18/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $47.2252, valued at $500.4k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
11/18/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $46.6559, valued at $494.3k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
11/18/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $46.6808, valued at $466.8k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
10/17/2019 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 2,285 shares @ $46.7, valued at $106.7k
10/17/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $46.8726, valued at $468.7k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
10/17/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $46.8871, valued at $496.8k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
09/16/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $25.2643, valued at $267.7k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
09/16/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $25.405, valued at $254.1k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
08/27/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $27.7703, valued at $277.7k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
08/27/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,595 shares @ $27.7703, valued at $294.2k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
08/27/2019 4 Ricardo Alonso (See Remarks) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 2,285 shares @ $27.8949, valued at $63.7k
07/18/2019 4 Read Simon (Chief Scientific Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $32.9479, valued at $329.5k
Exercised 10,000 options to buy @ $2.87, valued at $28.7k
07/16/2019 4 Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns: Sold 6,379 shares @ $32.969, valued at $210.3k
Sold 4,216 shares @ $33.287, valued at $140.3k
Exercised 1,389 options to buy @ $5.6, valued at $7.8k
Exercised 9,206 options to buy @ $5.6, valued at $51.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy